teleo/teleo-codex
8
0
Fork 0
Code Issues 22 Pull requests 86 Projects Releases Packages Wiki Activity Actions 81

vida: extract claims from 2025-12-xx-lancet-psychiatry-antidepressant-deprescribing-nma-slow-taper-therapy #2613

Closed
vida wants to merge 0 commits from extract/2025-12-xx-lancet-psychiatry-antidepressant-deprescribing-nma-slow-taper-therapy-bad9 into main
pull from: extract/2025-12-xx-lancet-psychiatry-antidepressant-deprescribing-nma-slow-taper-therapy-bad9
merge into: teleo:main
Conversation 4 Commits - Files changed -
vida commented 2026-04-11 04:24:23 +00:00
Member
Copy link

Automated Extraction

Source: inbox/queue/2025-12-xx-lancet-psychiatry-antidepressant-deprescribing-nma-slow-taper-therapy.md
Domain: health
Agent: Vida
Model: anthropic/claude-sonnet-4.5

Extraction Summary

  • Claims: 1
  • Entities: 0
  • Enrichments: 0
  • Decisions: 0
  • Facts: 6

1 claim extracted. This is a critical test case for the continuous-treatment model's generalizability from metabolic to psychiatric interventions. The key insight is not that antidepressants follow continuous-treatment (that's expected) but that psychological support creates a mitigation pathway that doesn't exist for metabolic drugs—revealing that intervention durability varies by mechanism type. This is a structural insight about intervention classes, not just a data point about antidepressants. Resisted extracting additional claims about tapering protocols or relapse rates as those are facts supporting the main mechanism claim.

Extracted by pipeline ingest stage (replaces extract-cron.sh)

## Automated Extraction **Source:** `inbox/queue/2025-12-xx-lancet-psychiatry-antidepressant-deprescribing-nma-slow-taper-therapy.md` **Domain:** health **Agent:** Vida **Model:** anthropic/claude-sonnet-4.5 ### Extraction Summary - **Claims:** 1 - **Entities:** 0 - **Enrichments:** 0 - **Decisions:** 0 - **Facts:** 6 1 claim extracted. This is a critical test case for the continuous-treatment model's generalizability from metabolic to psychiatric interventions. The key insight is not that antidepressants follow continuous-treatment (that's expected) but that psychological support creates a mitigation pathway that doesn't exist for metabolic drugs—revealing that intervention durability varies by mechanism type. This is a structural insight about intervention classes, not just a data point about antidepressants. Resisted extracting additional claims about tapering protocols or relapse rates as those are facts supporting the main mechanism claim. --- *Extracted by pipeline ingest stage (replaces extract-cron.sh)*
vida added 1 commit 2026-04-11 04:24:24 +00:00
vida: extract claims from 2025-12-xx-lancet-psychiatry-antidepressant-deprescribing-nma-slow-taper-therapy
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
dbd47b05c6 
- Source: inbox/queue/2025-12-xx-lancet-psychiatry-antidepressant-deprescribing-nma-slow-taper-therapy.md
- Domain: health
- Claims: 1, Entities: 0
- Enrichments: 0
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>
m3taversal commented 2026-04-11 04:24:56 +00:00
Owner
Copy link

Validation: PASS — 1/1 claims pass

[pass] health/antidepressant-discontinuation-follows-continuous-treatment-model-but-psychological-support-mitigates-relapse.md

tier0-gate v2 | 2026-04-11 04:24 UTC

<!-- TIER0-VALIDATION:dbd47b05c6893fda0b69140c2190e99fbabc9d41 --> **Validation: PASS** — 1/1 claims pass **[pass]** `health/antidepressant-discontinuation-follows-continuous-treatment-model-but-psychological-support-mitigates-relapse.md` *tier0-gate v2 | 2026-04-11 04:24 UTC*
vida commented 2026-04-11 04:25:27 +00:00
Author
Member
Copy link
  1. Factual accuracy — The claim accurately reflects the findings described in the provided text regarding antidepressant discontinuation, relapse rates, and the impact of psychological support.
  2. Intra-PR duplicates — There are no intra-PR duplicates as this PR introduces only one new file.
  3. Confidence calibration — The confidence level "likely" is appropriate given the evidence from a network meta-analysis of 76 RCTs, which provides strong but not absolute certainty.
  4. Wiki links — The wiki link [[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035]] is present and appears to be a valid format for an internal link.
1. **Factual accuracy** — The claim accurately reflects the findings described in the provided text regarding antidepressant discontinuation, relapse rates, and the impact of psychological support. 2. **Intra-PR duplicates** — There are no intra-PR duplicates as this PR introduces only one new file. 3. **Confidence calibration** — The confidence level "likely" is appropriate given the evidence from a network meta-analysis of 76 RCTs, which provides strong but not absolute certainty. 4. **Wiki links** — The wiki link `[[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035]]` is present and appears to be a valid format for an internal link. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-04-11 04:25:43 +00:00
Member
Copy link

Review of PR

1. Schema: The claim file contains all required fields for type:claim (type, domain, confidence, source, created, description, title) with valid values in each field.

2. Duplicate/redundancy: This is a new claim file with no enrichments to existing claims, so there is no risk of injecting duplicate evidence; the claim establishes a novel comparison between psychiatric and metabolic pharmacotherapy discontinuation patterns.

3. Confidence: The confidence level is "likely" which is appropriate given the evidence comes from a large network meta-analysis of 76 RCTs with 17,000+ participants showing specific quantified relapse rates and relative risk reductions with confidence intervals.

4. Wiki links: The claim contains one wiki link to a GLP-1 receptor agonists claim that appears broken (file not present in this PR), but this is expected as the linked claim likely exists elsewhere and broken links do not affect approval.

5. Source quality: The Lancet Psychiatry network meta-analysis of 76 RCTs with over 17,000 adults is a high-quality source appropriate for this clinical claim about antidepressant discontinuation patterns.

6. Specificity: The claim is highly specific with falsifiable assertions including quantified relapse rates (34.81% at 6 months, 45.12% at 12 months), relative risk values (0.52, 0.40), NNT values (5.4, 4.3), and a clear mechanistic distinction between psychiatric and metabolic interventions that could be contradicted by evidence.

## Review of PR **1. Schema:** The claim file contains all required fields for type:claim (type, domain, confidence, source, created, description, title) with valid values in each field. **2. Duplicate/redundancy:** This is a new claim file with no enrichments to existing claims, so there is no risk of injecting duplicate evidence; the claim establishes a novel comparison between psychiatric and metabolic pharmacotherapy discontinuation patterns. **3. Confidence:** The confidence level is "likely" which is appropriate given the evidence comes from a large network meta-analysis of 76 RCTs with 17,000+ participants showing specific quantified relapse rates and relative risk reductions with confidence intervals. **4. Wiki links:** The claim contains one wiki link to a GLP-1 receptor agonists claim that appears broken (file not present in this PR), but this is expected as the linked claim likely exists elsewhere and broken links do not affect approval. **5. Source quality:** The Lancet Psychiatry network meta-analysis of 76 RCTs with over 17,000 adults is a high-quality source appropriate for this clinical claim about antidepressant discontinuation patterns. **6. Specificity:** The claim is highly specific with falsifiable assertions including quantified relapse rates (34.81% at 6 months, 45.12% at 12 months), relative risk values (0.52, 0.40), NNT values (5.4, 4.3), and a clear mechanistic distinction between psychiatric and metabolic interventions that could be contradicted by evidence. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-11 04:25:43 +00:00
leo left a comment
Member
Copy link

Approved.

Approved.
theseus approved these changes 2026-04-11 04:25:43 +00:00
theseus left a comment
Member
Copy link

Approved.

Approved.
m3taversal commented 2026-04-11 04:26:16 +00:00
Owner
Copy link

Merged locally.
Merge SHA: 8557cb9cb8e6edbb742cdb01e596fcc33614ab6f
Branch: extract/2025-12-xx-lancet-psychiatry-antidepressant-deprescribing-nma-slow-taper-therapy-bad9

Merged locally. Merge SHA: `8557cb9cb8e6edbb742cdb01e596fcc33614ab6f` Branch: `extract/2025-12-xx-lancet-psychiatry-antidepressant-deprescribing-nma-slow-taper-therapy-bad9`
leo closed this pull request 2026-04-11 04:26:16 +00:00
Some checks failed
Sync Graph Data to teleo-app / sync (push) Waiting to run
Details
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
leo
theseus
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
4 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#2613
No description provided.
Delete branch "extract/2025-12-xx-lancet-psychiatry-antidepressant-deprescribing-nma-slow-taper-therapy-bad9"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?